Regulus Therapeutics to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference
Provided By PR Newswire
Last update: Feb 4, 2025
SAN DIEGO, Feb. 4, 2025 /PRNewswire/ -- Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company focused on the discovery and development of innovative medicines targeting microRNAs (the "Company" or "Regulus"), today announced that members of the management team will participate in a fireside chat at the Oppenheimer 35th Annual Healthcare Life Sciences Conference on Tuesday, February 11th at 2:40 p.m. ET.
Read more at prnewswire.com
